Show
Sort by
-
- Journal Article
- A2
- open access
EUFOREA summit in Brussels 2023 : inspiring the future of allergy & respiratory care
-
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis
-
Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps
(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB144-AB144 -
Dupilumab achieves durable reduction in severity of symptoms rated most important by patients with chronic rhinosinusitis with nasal polyps
(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 149(2). p.AB142-AB142 -
- Journal Article
- A1
- open access
Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds
-
- Journal Article
- A1
- open access
Association between outdoor air pollution and chronic rhinosinusitis patient reported outcomes
-
Role of biologics in chronic rhinosinusitis with nasal polyposis : state of the art review
-
ARIA digital anamorphosis : digital transformation of health and care in airway diseases from research to practice
-
- Journal Article
- A1
- open access
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
-
Cabbage and fermented vegetables : from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19